Introduction {#sec0001}
============

The reconstructive challenge posed by complete facial paralysis is to optimally restore meaningful facial function and an acceptable cosmesis with minimal residual patient morbidity[@bib0001].

Although meshes are the most commonly used biomaterials in medical practice, with approximately 1.5 million implants used per year[@bib0002], numerous questions remain unaddressed about the host inflammatory response induced by mesh implants[@bib0003].

The utilization of alloplastic material (i.e. silicone prostheses, polypropylene mesh, etc.) in plastic surgery has been widely accepted. Polypropylene (PP) is the most commonly used material to manufacture meshes, nonetheless several other absorbable and non-absorbable materials are also being used[@bib0004], [@bib0005].

Whatever be the nature of the material employed, some inflammatory reaction is bound to occur[@bib0006].

The host response to implanted mesh follows a cascade of events involved in wound healing including coagulation, inflammation, angiogenesis, epithelialization, fibroplasia, matrix deposition, and contraction[@bib0007], [@bib0008], [@bib0009].

At the same time, experimental data reveal that material composition and mesh structure may significantly affect foreign body reaction.[@bib0010]

Mesh characteristics such as pore size, chemical composition, filament structure, amount of implanted material, and biodegradability affect the processes of inflammation, angiogenesis, and tissue formation which consequently may alter wound healing[@bib0011], [@bib0012], [@bib0013], [@bib0014], [@bib0015], [@bib0016], [@bib0017]. Theoretically, the increased diameter of the pores and the reduction in the density of meshes could minimize inflammation and, consequently reduce the complications related to these implants[@bib0018], [@bib0019], [@bib0020], [@bib0021].

According to data from current randomized controlled trials and retrospective studies, light meshes seem to have some advantages with respect to postoperative pain and foreign body sensation. Experimental studies have shown that the inflammatory response of an organism toward titanium-coated meshes is much reduced when compared with other implants.[@bib0021], [@bib0022]

Bearing this in mind, this experiment was performed to test the reaction of soft tissues to Titanium mesh implant ("Titanium Silk" developed by TsKB RAS, manufacturer: OOO TEMP, Yekaterinburg, Russia).Properties of "Titanium silk":FeaturesValueComposition99.9% titaniumSurface density (Weight)35--60 g/m ^2^Pore size1--3 mmThread thickness (Filament diameter)65 μm (65 μm)Porosity (3D--weaving)91%Elasticity (Physiological elasticity at 16 N/cm)38--46%  (More details can be found at the Manufacturer\'s website: http://titanell.com/2015/05/15/another-interesting-single-post/)

This article is the outcome of an elaborate research in mice on tissue response to Titanium mesh implant with subsequent clinical application for soft tissue reinforcement.

Objective {#sec0002}
=========

The objective of this experiment has been to determine the least reactive and highly efficient alloplastic material for mesh implant in treating Facial Paralysis and mandibular injuries revealing minimal inflammatory response along with reduced postoperative pain and foreign body sensation.

Materials and methods {#sec0003}
=====================

The experiment was conducted under standard laboratory conditions. A group of 89 mice was randomly segregated into four groups with a control group of 5 mice serving as a comparative evaluation of general health condition and behavioral reactions as implantation was not performed in this group. The first experimental group of 28 mice was implanted with a titanium mesh implant "Titanium Silk". In the second experimental group of 28 mice, a self-fixating partially bio-degradable mesh implant based on polylactic acid and polypropylene "Parietene Progrip" was implanted while in the third group of 28 mice, a polypropylene mesh implant "Prolene" was implanted.

All experimental operations were carried out under inhalation anesthesia with ethyl ether. At the withers, following antiseptic treatment, a sharp linear incision of 15 mm was made. Further, blunt dissection was done to create a subcutaneous pocket of 15 × 15 mm and a sterile implant sample of 10 × 10 mm was placed. Skin was closed with sutures and antiseptics applied. The stages of implantation are shown in Video 1 - Stages of the experimental operation.Figure 1Gr 1 Macro-Photo \`Titanium Silk\' (Day 60).Fig 1

In each group, the overall health condition of the mice, including behavioral responses and body mass dynamics were evaluated.

Clinically, in the wound area, postoperative edema was observed in all groups for the first 2 days. There was no marked painful reaction during palpation over the implant placement area. Subsequently, all wounds healed with primary intention, without any suppuration.

Following euthanasia with 100% CO~2~, musculocutaneous tissue units of 7 mice (from each experimental group with sample implants) were studied on days 7, 14, 30, and 60. A macro preparation was made and macrophotography was carried out using a digital USB microscope MIKMED-LCD (PRC) with magnification of 100--200 times (Figures 1, 2 and 3). Also, the resulting tissue samples were fixed with 10% formalin solution and micro preparations were made for histological examination.

The software 'GraphPad Prism 7 (USA)' was used for statistical evaluation of data and creation of graphs. For sorting of groups, the different types of implant were chosen.

As the groups included a small number of observations (*n*=7), and the values of investigated parameters were presented in a point discrete scale, bilateral non-parametric tests were used to identify inter- and intra-group differences.

Comparison between the three study groups, at the same observation times, were performed using the Kruskal--Wallis test with Dunn\'s *post hoc* test. The dynamics of changes in the study parameters during the observation period was also assessed using Dunn\'s test for independent samples.

Results {#sec0004}
=======

General observation {#sec0005}
-------------------

In the experimental groups, there were no clinically significant differences among the mice during the postoperative period. The animals were active within an hour of operation. During observation, typical behavioral reactions known for these types of experimental animals were noted in all groups: mice were actively moving around the cell, food and water was consumed normally. The daily remainder of food and drink in animals in the groups did not differ significantly. The increase in body weight, as an integral measure of the general state of the animal, is presented in [Table 1](#tbl0001){ref-type="table"}.Table 1Weight gain of experimental animals.Table 1GroupThe periods of observation, weight (gms)Initially7 days14 days30 days60 daysControl287 ± 28344 ± 31361 ± 28364 ± 20409 ± 291- Group291 ± 46**306 ± 38**[\*](#tb1fn1){ref-type="table-fn"}345 ± 48329 ± 43396 ± 392- Group273 ± 49**303 ± 48**[\*](#tb1fn1){ref-type="table-fn"}**321 ± 42**[\*](#tb1fn1){ref-type="table-fn"}**296 ± 54**[\*](#tb1fn1){ref-type="table-fn"}383 ± 453- Group283 ± 38**306 ± 38**[\*](#tb1fn1){ref-type="table-fn"}**333 ± 40**[\*](#tb1fn1){ref-type="table-fn"}340 ± 47407 ± 26[^1]

Gross anatomy {#sec0006}
-------------

Refer to Macro-Photographs at Day 60:1.The results of an indirect assessment of bio-compatibility of implant studies showed that titanium-containing reticular implant "TITANIUM SILK" was the most bio-inert. This group of mice quickly gained weight, and formed a soft connective tissue capsule loosely adherent to the adjacent connective tissue structures (dermis, superficial fascia) around the implant ([Figure 1](#fig0001){ref-type="fig"}).2.Self-fixating semi-resorbable mesh implant "PARIETENE PROGRIP" caused marked neo-angiogenesis inducing a tissue reaction. A firmly adherent connective tissue capsule was formed, which led the implant to be tightly fixed to the dermis and superficial fascia ([Figure 2](#fig0002){ref-type="fig"}).Figure 2Gr 2 Macro-Photo \'Parietene Progrip\' (Day 60).Fig 23.Implants "PROLENE" were characterized by the formation of a pronounced connective tissue capsule, which tended to be tightly fixed to the superficial fascia but had loosely and sparsely adherent to the dermis ([Figure 3](#fig0003){ref-type="fig"}).Figure 3Gr 3 Macro-Photo \'Prolene\' (Day 60).Fig 3

The final conclusions about the nature of tissue reaction to the implants under investigation can be formulated according to the results of its histological examination.

Histological analysis {#sec0007}
---------------------

### Macrophage infiltration {#sec0008}

In the first and third group, which used titanium mesh and polypropylene mesh implant \"Prolene\" respectively, a statistically significant greater macrophage infiltration was observed on the 7th day as compared to the 60th day ([Figures 4](#fig0004){ref-type="fig"},[Figure 7](#fig0007){ref-type="fig"}, [Figure 12](#fig0012){ref-type="fig"}, [Figure 14](#fig0014){ref-type="fig"}, [Graph 1](#fig0015){ref-type="fig"}, [Table 2](#tbl0002){ref-type="table"}, [3](#tbl0003){ref-type="table"}). In the second group with "Parietene Progrip", it was less expressed on the 7th day, increasing on the 14th day with a marked decrease on the 30^th^ day ([Figure 8](#fig0008){ref-type="fig"}, [Figure 9](#fig0009){ref-type="fig"}, [Figure 10](#fig0010){ref-type="fig"}, Graph). Statistically significant differences between the study groups throughout the periods of observation were not detected ([Table 4](#tbl0004){ref-type="table"}).Scoring points for 'Macrophage infiltration':1 point - single macrophages;2 points - moderate macrophage infiltration;3 points - pronounced macrophage infiltration.Figure 4Gr 1-Titan 7 days.Fig 4Table 2Values in points amidst the groups over time.Table 2GroupHistological analysis7 Days14 Days30 Days60 Days**FIRST group**Macrophages Infiltration2 \[2; 3\]2 \[2; 2\]2 \[1.5; 2\]1.5 \[0.75; 2\]Giant Cell Infiltration1 \[0; 1\]0 \[0; 1\]0 \[0; 0\]0 \[0; 1\]Meshwork around Fibers0 \[0; 0\]0 \[0; 1\]0 \[0; 0\]0 \[0; 0\]Connective Tissue Volume3 \[3; 3\]2 \[2; 2\]2 \[2; 2\]2 \[2; 2\]Vascular bed volume1 \[1; 2\]2 \[1; 2\]1 \[0; 1\]1 \[1; 2\]Fibroblast density2 \[2; 2\]1 \[1; 1\]1 \[1; 2\]1 \[1; 1\]**SECOND group**Macrophages infiltration2 \[0.75;2\]2 \[2;2\]2 \[2;3\]1.5 \[0.75;2\]Giant cell infiltration1 \[0;2\]0 \[0;1\]0 \[0;2\]1 \[0;1\]Meshwork around fibers0 \[0; 0\]0 \[0; 0\]0 \[0; 1\]1 \[1; 1\]Connective tissue volume3 \[2; 3\]3 \[3; 3\]3 \[2; 3\]2 \[2; 2\]Vascular bed volume1 \[1; 2\]1 \[1; 2\]1 \[1; 2\]2 \[2; 2\]Fibroblast density1 \[1; 2\]1 \[1; 2\]2 \[1; 2\]1 \[1; 1\]**THIRD group**Macrophages infiltration2 \[2;3\]2 \[2;2\]2 \[2;2\]1 \[0;2\]Giant cell infiltration1 \[1;1\]1 \[0;1\]1 \[1;1\]0 \[0;1\]Meshwork around fibers0 \[0; 1\]1 \[0; 1\]0 \[0; 1\]1 \[1; 1\]Connective tissue volume2 \[2; 3\]2 \[2; 3\]2 \[2; 2\]2 \[2; 2\]Vascular bed volume2 \[1; 2\]2 \[2; 2\]1 \[1; 2\]2 \[1; 2\]Fibroblast density2 \[1; 2\]1 \[1; 2\]1 \[1; 2\]1 \[1; 1\]Table 3INTRA-group changes over time (Dunn test).Table 3GroupHistological analysisAt 7 & 14 daysAt 7 & 30 daysAt 7 & 60 DaysAt 14 & 30 DaysAt 14 & 60 DaysAt 30 & 60 Days**FIRST Group**Macrophages infiltration*P*\>0.990.510.03\>0.990.51\>0.99Difference?NoNo**Yes**NoNoNoGiant cell infiltration*P*\>0.990.040.60.6\>0.99\>0.99Difference?No**Yes**NoNoNoNoMeshwork around fibers*P*0.25\>0.99\>0.990.250.25\>0.99Difference?NoNoNoNoNoNoConnective tissue volume*P*0.0030.020.02\>0.99\>0.99\>0.99Difference?**YesYesYes**NoNoNoVascular bed volume*P*\>0.990.12\>0.990.03\>0.990.12Difference?NoNoNo**Yes**NoNoFibroblast density*P*0.0030.120.003\>0.99\>0.99\>0.99Difference?**Yes**No**Yes**NoNoNo**SECOND Group**Macrophages infiltration*P*\>0.990.21\>0.99\>0.990.590.05Difference?NoNoNoNoNoNoGiant cell infiltration*P*\>0.99\>0.99\>0.99\>0.99\>0.99\>0.99Difference?NoNoNoNoNoNoMeshwork around fibers*P*\>0.99\>0.990.006\>0.99\<0.0010.04Difference?NoNo**Yes**No**YesYes**Connective tissue volume*P*\>0.99\>0.990.7\>0.990.040.13Difference?NoNoNoNo**Yes**NoVascular bed volume*P*\>0.99\>0.990.21\>0.990.050.21Difference?NoNoNoNoNoNoFibroblast density*P*\>0.99\>0.99\>0.99\>0.99\>0.990.74Difference?NoNoNoNoNoNo**THIRD Group**Macrophages infiltration*P*\>0.99\>0.990.01\>0.990.340.34Difference?NoNo**Yes**NoNoNoGiant cell infiltration*P*0.84\>0.990.01\>0.990.640.19Difference?NoNo**Yes**NoNoNoMeshwork around fibers*P*\>0.99\>0.990.08\>0.99\>0.990.08Difference?NoNoNoNoNoNoConnective tissue volume*P*\>0.99\>0.990.16\>0.990.61\>0.99Difference?NoNoNoNoNoNoVascular bed volume*P*\>0.99\>0.99\>0.990.64\>0.99\>0.99Difference?NoNoNoNoNoNoFibroblast density*P*\>0.99\>0.990.04\>0.990.640.64Difference?NoNo**Yes**NoNoNoTable 4INTER-group changes over time (Dunn test).Table 4GroupHistological analysis7 Days14 Days30 Days60 Days*P*Difference*P*Difference*P*Difference*P*Difference**FIRST Group & SECOND Group**Macrophages infiltration0.15No\>0.99No\>0.99No\>0.99NoGiant cell infiltration\>0.99No0.2No0.2No0.85NoMeshwork around fibers\>0.99No0.55No0.55No\<0.001**Yes**Connective tissue volume0.85No0.07**Yes**0.07No\>0.99NoVascular bed volume\>0.99No0.05No0.05**Yes**0.08NoFibroblast density0.24No0.88No0.88No0.66No**FIRST Group & THIRD Group**Macrophages infiltration\>0.99No\>0.99No\>0.99No\>0.99NoGiant cell infiltration0.51No0.02No0.02**Yes**\>0.99NoMeshwork around fibers0.41No0.55No0.55No\<0.001**Yes**Connective tissue volume0.32No\>0.99No\>0.99No0.7NoVascular bed volume\>0.99No0.05No0.05**Yes**\>0.99NoFibroblast density\>0.99No\>0.99No\>0.99No\>0.99No**SECOND Group & THIRD Group**Macrophages Infiltration0.15No\>0.99No\>0.99No\>0.99NoGiant cell infiltration\>0.99No\>0.99No\>0.99No0.85NoMeshwork around fibers\>0.99No\>0.99No\>0.99No\>0.99NoConnective tissue volume\>0.99No0.07No0.07No\>0.99NoVascular bed volume\>0.99No\>0.99No\>0.99No0.29NoFibroblast density\>0.99No\>0.99No\>0.99No\>0.99No

### Giant cells (Multinucleated macrophages) {#sec0009}

In the first group, statistically significant multinucleated macrophage infiltration was observed on the 7th day ([Figure 4](#fig0004){ref-type="fig"}) in comparison with the 30th day ([Figure 6](#fig0006){ref-type="fig"}). In the third group, statistically significant large macrophage infiltration was observed on the 7th day ([Figure 12](#fig0012){ref-type="fig"}) in comparison with that on the 60th day ([Figure 14](#fig0014){ref-type="fig"}, [Graph 2](#fig0016){ref-type="fig"}, [Table 2](#tbl0002){ref-type="table"}, [Table 3](#tbl0003){ref-type="table"}). Statistically significant differences were noticed on the 30th day of observation: the number of multi-nucleated macrophages in the first group was lower than that in the third group ([Table 4](#tbl0004){ref-type="table"}).Scoring points for the presence of 'multinucleated macrophages':0 point - none.1 point - multinuclear macrophages occur in a single field of vision.2 points - multinuclear macrophages are found in most fields of vision.

### Meshwork around the implant fibers {#sec0010}

In the second group, where the self-retaining bio-resorbable mesh "Parietene Progrip" was used, a statistically significant increase in the volume of meshwork around the filaments of the mesh was observed on the 60th day ([Figure 11](#fig0011){ref-type="fig"}) in comparison to all previous periods ([Graph 3](#fig0017){ref-type="fig"}, [Table 2](#tbl0002){ref-type="table"}, [Table 3](#tbl0003){ref-type="table"}). Statistically significant differences between the first and the second, and also between the first and the third group, were found on the 60th day ([Figure 7](#fig0007){ref-type="fig"}, [Figure 11](#fig0011){ref-type="fig"}, [Figure 14](#fig0014){ref-type="fig"}). The volume of meshwork around the filaments in the first group was significantly less than that in the second and the third groups ([Table 4](#tbl0004){ref-type="table"}).Scoring points for the presence of connective tissue Meshwork around the implant fibers:0 point -- meshwork is not detected.1 point - moderately pronounced meshwork.2 points - significantly pronounced meshwork.

### Connective tissue {#sec0011}

In the first group, a significant decrease in the volume of connective tissue was observed on the 14th, 30th and 60th days ([Figure 5](#fig0005){ref-type="fig"}, [Figure 6](#fig0006){ref-type="fig"}, [Figure 7](#fig0007){ref-type="fig"}), compared with that on the 7th day ([Figure 4](#fig0004){ref-type="fig"}). In the second group, a statistically significant decrease in the volume of the connective tissue on the 60th day ([Figure 11](#fig0011){ref-type="fig"}) as compared to that on the 14th day ([Figure 9](#fig0009){ref-type="fig"}, [Graph 4](#fig0018){ref-type="fig"}, [Table 2](#tbl0002){ref-type="table"}, [Table 3](#tbl0003){ref-type="table"}). On the 14th day, a statistically significant less amount of connective tissue was observed in the first group over that in the second ([Table 4](#tbl0004){ref-type="table"}).Figure 5Gr 1-Titan 14 days.Fig 5Figure 6Gr 1-Titan 30 days.Fig 6Figure 7Gr 1-Titan 60 days.Fig 7

The degree of growth of connective tissue at the beginning and the end of the experiment was approximately the same in all groups. However, there was a characteristic increase of the connective tissue of the second group at the 2nd and 3rd week of experiment.Scoring points for the formation of connective tissue was assessed by the density of its growth:1 point - connective tissue not expressed.2 points - connective tissue weakly expressed.3 points - connective tissue moderately expressed.4 points - connective tissue significantly expressed.

### Angiogenesis {#sec0012}

The first group observed a significant decrease in vascular volume on the 14th day as compared with that on the 7th day ([Figure 4](#fig0004){ref-type="fig"}, [Figure 5](#fig0005){ref-type="fig"}, [Graph 5](#fig0019){ref-type="fig"}, [Table 2](#tbl0002){ref-type="table"}, [Table 3](#tbl0003){ref-type="table"}). On 30th day, significantly lesser amount of connective tissue in the first group was observed than that on the second and the third groups ([Figure 6](#fig0006){ref-type="fig"}, [Figure 10](#fig0010){ref-type="fig"}, [Figure 13](#fig0013){ref-type="fig"}, [Table 4](#tbl0004){ref-type="table"}).Scoring points for Angiogenesis was as per the number of vessels around the mesh filaments.0 point - vessels not detected.1 point - a single vessel seen.2 points - multiple vessels seen.

### Fibroblasts {#sec0013}

In the first group, a significantly less number of fibroblasts was observed on the 14th day ([Figure 5](#fig0005){ref-type="fig"}) and the 60th day ([Figure 7](#fig0007){ref-type="fig"}) as compared with that on the 7th day ([Figure 4](#fig0004){ref-type="fig"}). In the second group, a significant decrease was noted on the 60th day ([Figure 11](#fig0011){ref-type="fig"}) as compared with that on the 7th day ([Figure 8](#fig0008){ref-type="fig"}, [Graph 6](#fig0020){ref-type="fig"}, [Table 2](#tbl0002){ref-type="table"}, [Table 3](#tbl0003){ref-type="table"}).Scoring points for the density of fibroblasts:0 point - fibroblasts are not detected.1 point -- fibroblasts are sparse.2 points - fibroblasts are densely localized.Figure 8Gr 2-Parietene Pro 7 days.Fig 8Figure 9Gr 2-Parietene Pro 14 days.Fig 9Figure 10Gr 2-Parietene Pro 30 days.Fig 10Figure 11Gr 2-Parietene Pro 60 days.Fig 11Figure 12Gr 3-Prolene 7 days.Fig 12Figure 13Gr 3-Prolene 30 days.Fig 13Figure 14Gr 3-Prolene 60 days.Fig 14Graph 1Intensity of macrophage infiltration in the comparison group at different days.**Herein and hereafter:**The symbol \"------\" indicates a statistically significant **[Inter-group difference]{.ul}** (Dunn\'s test, *p*\<0.05).The symbols \*, \*\*, \*\*\*, +, \# etc., indicates **[Intra-group differences]{.ul}** between the study parameters at different time periods, identified in pairwise comparison (Dunn\'s test, *p*\<0.05).Fig 15Graph 2Expression of Multinuclear Macrophages (Giant Cells) infiltration amidst comparison groups over time.**Herein and hereafter:**The symbol \"------\" indicates a statistically significant **[Inter-group difference]{.ul}** (Dunn\'s test, *p* \< 0.05).The symbols \*, \*\*, \*\*\*, +, \# etc., indicates **[Intra-group differences]{.ul}** between the study parameters at different time periods, identified in pairwise comparison (Dunn\'s test, *p* \< 0.05).Fig 16Graph 3The severity of Meshwork Around the implant fibers between the groups over time.**Herein and hereafter:**The symbol \"------\" indicates a statistically significant **[Inter-group difference]{.ul}** (Dunn\'s test, *p* \< 0.05).The symbols \*, \*\*, \*\*\*, +, \# etc., indicates **[Intra-group differences]{.ul}** between the study parameters at different time periods, identified in pairwise comparison (Dunn\'s test, *p* \< 0.05).Fig 17Graph 4Volume of Connective Tissue between groups over time.**Herein and hereafter:**The symbol \"------\" indicates a statistically significant **[Inter-group difference]{.ul}** (Dunn\'s test, *p* \< 0.05).The symbols \*, \*\*, \*\*\*, +, \# etc., indicates **[Intra-group differences]{.ul}** between the study parameters at different time periods, identified in pairwise comparison (Dunn\'s test, *p* \< 0.05).Fig 18Graph 5Volume of the Vessels (vascular bed) between groups over time.**Herein and hereafter:**The symbol \"------\" indicates a statistically significant **[Inter-group difference]{.ul}** (Dunn\'s test, *p* \< 0.05).The symbols \*, \*\*, \*\*\*, +, \# etc., indicates **[Intra-group differences]{.ul}** between the study parameters at different time periods, identified in pairwise comparison (Dunn\'s test, *p* \< 0.05).Fig 19Graph 6The density of fibroblasts between the groups over time.**Herein and hereafter:**The symbol \"------\" indicates a statistically significant **[Inter-group difference]{.ul}** (Dunn\'s test, *p* \< 0.05).The symbols \*, \*\*, \*\*\*, +, \# etc., indicates **[Intra-group differences]{.ul}** between the study parameters at different time periods, identified in pairwise comparison (Dunn\'s test, *p* \< 0.05).Fig 20

Statistically significant differences between the study groups at all stages of monitoring were identified. ([Table 4](#tbl0004){ref-type="table"})

All statistical data is presented in Tables 2, 3 and 4.

Discussion {#sec0014}
==========

The presented data (in Table 1) indicated that postoperatively during the first week, there was a physiological reaction to the invasive procedure as manifested by a statistically significant difference in the body weight gain of the animals between the groups i.e. the control group and the experimental groups. However, within the experimental groups, there were no statistically significant differences in the weight gain amongst the rodents. On the 14th day of observation, statistically significant differences in the body weight of the mice of the second and third test groups were noted, which, was apparently inferred being due to the continued reaction of the body to the implant. On the 30th day, the lag in the weight gain of the mice were persistent in the second group with partially biodegradable "PARIETENE PROGRIP" implant. On the 60th day, no significant differences in the weight gain among the groups indicated completion of main, energy-dependent biological reactions for implantation of synthetic compositions.

Conclusion {#sec0015}
==========

Histological analysis of titanium mesh implant demonstrated the formation of a firm yet flexible connective tissue meshwork which reduced the possibility of implant contouring and deformation within the thin connective tissues, and thus, it can be considered as a highly suitable implant for static correction in patients with facial paralysis. However, for a more accurate and stable management, postoperatively it was found worth considering a healing timeframe of 30 days for the formation of a full-fledged connective tissue around the grid elements. Thus, the final analysis suggested that the use of titanium mesh for static correction of Facial paralysis and mandibular reconstruction is promising. The results of our clinical application of "Titanium Silk" for static correction of Facial Paralysis -- shall be topic of a subsequent article.

Video 1. Stages of the experimental operation.

Appendix. Supplementary materials {#sec0019}
=================================

Image, video 1
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[^1]: statistically significant difference (*p* ≤ 0.05) to the control group in the same period of observation (to evaluate the statistical significance of differences between groups 'Mann--Whitney *U* test' was used)
